Key result
Nichi Glucan lowers HbA1c to target in two of three diabetes patients.
Case Report (n=3)
Answers are grounded in this paper and cite their sources.
Beta Glucan food supplements have been reported to be of benefit in diabetes and hyperlipidemia. We report a pilot study of the effects of Nichi Glucan, 1, 3-1, 6 Beta Glucan food supplement, in lowering the blood glucose and lipid levels in three patients with noninsulin-dependent diabetes mellitus (NIDDM) from India. These patients had increased blood glucose and lipid levels inspite of routine antidiabetic and lipid level lowering medications. Each of the participants took 1.5 g of Nichi Glucan per day with food for two months along with their routine medications. The relevant parameters to assess glycemic status and lipid levels were calculated at the baseline and at the end of two months. After two months of continuous consumption, in one patient, the HbA1c decreased from 9.1% to 7.8%, and the glycemic target of HbA1c <6.5% laid down by the International Diabetes Federation was reached in two patients. Lipid levels also decreased significantly. Based on our findings, Nichi Glucan food supplement can be considered along with routine medications in patients with Type II diabetes with hyperlipidemia. Further studies are needed to validate the results.
No takes yet. Share an insight, caveat, or question.
Dedeepiya et al. (2012) conducted a case report in Noninsulin-dependent diabetes mellitus (NIDDM) and hyperlipidemia (n=3). Nichi Glucan (1,3-1,6 Beta Glucan food supplement) was evaluated on Glycemic status (HbA1c) and lipid levels. Nichi Glucan achieved HbA1c <6.5% in 2 of 3 diabetes patients, lowered HbA1c from 9.1% to 7.8% in the third, and decreased lipid levels.
Synapse has enriched 10 related papers. Consider them for comparative context: